Mechanism of Action: Potassium Channel Antagonists
✉ Email this page to a colleague
Drugs with Mechanism of Action: Potassium Channel Antagonists
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Macleods Pharms Ltd | REPAGLINIDE | repaglinide | TABLET;ORAL | 207209-003 | Mar 22, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Aurobindo Pharma Ltd | REPAGLINIDE | repaglinide | TABLET;ORAL | 203820-002 | Jan 22, 2014 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Aurobindo Pharma Ltd | REPAGLINIDE | repaglinide | TABLET;ORAL | 203820-003 | Jan 22, 2014 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |